The global CBD nutraceuticals market size is expected to reach USD 19.25 billion by 2028
The demand for CBD nutraceuticals is expected to increase during the forecast period owing to increasing obesity and related disorders, growing health consciousness, and greater awareness regarding benefits associated with cannabidiol nutraceuticals. The legalization of the U.S. Farm Bill in late 2018 leading to the commercialization of hemp-derived products, increasing disposable income of consumers, and growing shift towards health and wellness products has significantly increased the demand for cannabidiol nutraceuticals.
In March 2018, MGC Pharma expanded its product portfolio through the introduction of cannabis and hemp-enhanced nutraceutical products. The company launched several vegan products including supplements and food-grade products under its new line, MGC Nutraceuticals. Its new offerings include capsules, water-soluble cannabinoids, and ready-to-drink products containing high-grade phytocannabinoids aimed at reducing stress, boosting immunity, and maintaining muscle and bone structure. This product launch enables the company to tap growing opportunities in the dietary supplement and cannabidiol nutraceuticals market.